A New Four-day Regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide, and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized Clinical Trial.

Trial Profile

A New Four-day Regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide, and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized Clinical Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Nov 2010

At a glance

  • Drugs Nitazoxanide (Primary) ; Amoxicillin; Clarithromycin; Dexlansoprazole; Doxycycline; Lansoprazole; Levofloxacin; Moxifloxacin; Omeprazole
  • Indications Dyspepsia; Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2010 New trial record
    • 20 Oct 2010 Results were presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top